Advanced oxidation protein products inhibit differentiation and activate inflammation in 3T3-L1 preadipocytes

Journal of Cellular Physiology

Volumn 225, Issue 1, 2010, Pages 42-51

  Zhou, Qiu Gen ^a,b   Peng, Xin ^a,b   Hu, Li Li ^a,b   Xie, Di ^a,b   Zhou, Min ^a,b   Hou, Fan Fan ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN; FATTY ACID BINDING PROTEIN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CLINICAL ASSESSMENT; ENZYME INDUCTION; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; INFLAMMATION; MICE; OXIDATION-REDUCTION; PROTEINS; RNA-BINDING PROTEINS; TRANSCRIPTION FACTOR CHOP;

EID: 77956526220     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22189     Document Type: Article

References (38)

1. Atabek ME, Keskin M, Yazici C, Kendirci M, Hatipoglu N, Koklu E, Kurtoglu S. 2006. Protein oxidation in obesity and insulin resistance. Eur J Pediatr 165:753-756.
2. Batchvarova N, Wang XZ, Ron D. 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J 14:4654-4661.
3. Cartwright MJ, Tchkonia T, Kirkland JL. 2007. Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms. Exp Gerontol 42:463-471. (Pubitemid 46756096)
4. Charriere G, Cousin B, Arnaud E, Andre M, Bacou F, Penicaud L, Casteilla L. 2003. Preadipocyte conversion to macrophage. Evidence of plasticity. J Biol Chem 278:9850-9855.
5. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen SM, McIntosh MK. 2006. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147:5340-5351.
6. Darlington GJ, Ross SE, MacDougald OA. 1998. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273:30057-30060.
7. Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome. Lancet 365:1415-1428.
8. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, Zhang X. 2008. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 10:1699-1712.
9. Gustafson B, Hammarstedt A, Andersson CX, Smith U. 2007. Inflamed adipose tissue: A culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27:2276-2283. (Pubitemid 350203940)
10. Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U. 2009. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab. 297:E999-E1003.
11. Isakson P, Hammarstedt A, Gustafson B, Smith U. 2009. Impaired preadipocyte differentiation in human abdominal obesity: Role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 58:1550-1557.
12. Iwao Y, Nakajou K, Nagai R, Kitamura K, Anraku M, Maruyama T, Otagiri M. 2008. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol 295:F1871-F1880.
13. Kalousova M, Skrha J, Zima T. 2002. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597-604. (Pubitemid 36168668)
14. Karagiannides I, Thomou T, Tchkonia T, Pirtskhalava T, Kypreos KE, Cartwright A, Dalagiorgou G, Lash TL, Farmer SR, Timchenko NA, Kirkland JL. 2006. Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem 281:23025-23033.
15. Krzystek-Korpacka M, Patryn E, Boehm D, Berdowska I, Zielinski B, Noczynska A. 2008. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction. Clin Biochem 41:943-949.
16. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. 2007. Macrophage-secreted factors impair human adipogenesis: Involvement of proinflammatory state in preadipocytes. Endocrinology 148:868-877.
17. Laclaustra M, Corella D, Ordovas JM. 2007. Metabolic syndrome pathophysiology: The role of adipose tissue. Nutr Metab Cardiovasc Dis 17:125-139. (Pubitemid 46240796)
18. Lewis GF, Carpentier A, Adeli K, Giacca A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229.
19. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
20. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. 2007. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 18:528-538.
21. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, Zhang X. 2006. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26:1156-1162.
22. Mack I, BelAiba RS, Djordjevic T, Gorlach A, Hauner H, Bader BL. 2009. Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNFalpha exposure. Am J Physiol Endocrinol Metab 297:E735-E748.
23. Marsche G, Semlitsch M, Hammer A, Frank S, Weigle B, Demling N, Schmidt K, Windischhofer W, Waeg G, Sattler W, Malle E. 2007. Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway. FASEB J 21:1145-1152.
24. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. 2003. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 34:1563-1574. (Pubitemid 36638716)
25. Permana PA, Nair S, Lee YH, Luczy-Bachman G, Vozarova De Courten B, Tataranni PA. 2004. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab 286:E958-E962.
26. Rajala MW, Scherer PE. 2003. Minireview: The adipocyte - At the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773.
27. Rasouli N, Molavi B, Elbein SC, Kern PA. 2007. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes Metab 9:1-10.
28. Ravussin E, Smith SR. 2002. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363-378. (Pubitemid 34721922)
29. Rosen ED, Spiegelman BM. 2000. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145-171.
30. Shi XY, Hou FF, Niu HX, Wang GB, XieD, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X. 2008. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149:1829-1839.
31. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. 2008. Dynamics of fat cell turnover in humans. Nature 453:783-787.
32. Tchkonia T, Pirtskhalava T, Thomou T, Cartwright MJ, Wise B, Karagiannides I, Shpilman A, Lash TL, Becherer JD, Kirkland JL. 2007. Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis. Am J Physiol Endocrinol Metab 293:E1810-E1819.
33. Tchoukalova Y, Koutsari C, Jensen M. 2007. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 50:151-157. (Pubitemid 46035863)
34. van Herpen NA, Schrauwen-Hinderling VB. 2008. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94:231-241.
35. Wei XF, Zhou QG, Hou FF, Liu BY, Liang M. 2009. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296:F427-F437.
36. Wu Z, Bucher NL, Farmer SR. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 16:4128-4136.
37. Zhou Q, Du J, Hu Z, Walsh K, Wang XH. 2007. Evidence for adipose-muscle cross talk: Opposing regulation of muscle proteolysis by adiponectin and fatty acids. Endocrinology 148:5696-5705.
38. Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, Tian JW. 2009. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 76:1148-1160.